Novo Nordisk Aktie
51,21
EUR
-0,02
EUR
-0,04
%
51,51
EUR
+3,41
EUR
+7,09
%
Werbung
Novo Nordisk Aktie Analyse
| 08.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.02.21 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.21 | Novo Nordisk Neutral | Credit Suisse Group | |
| 04.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novo Nordisk Outperform | Bernstein Research | |
| 03.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novo Nordisk Neutral | UBS AG | |
|
Werbung
|
|||
| 03.02.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 26.01.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.01.21 | Novo Nordisk Neutral | Credit Suisse Group | |
| 20.01.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 18.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.01.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 04.01.21 | Novo Nordisk kaufen | JP Morgan Chase & Co. | |
| 17.12.20 | Novo Nordisk Neutral | UBS AG | |
| 01.12.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.11.20 | Novo Nordisk Neutral | UBS AG | |
| 09.11.20 | Novo Nordisk Underweight | Morgan Stanley | |
| 06.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.11.20 | Novo Nordisk Neutral | UBS AG | |
| 02.11.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 30.10.20 | Novo Nordisk kaufen | Bernstein Research | |
| 30.10.20 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.10.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 30.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 30.10.20 | Novo Nordisk Neutral | UBS AG | |
| 30.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.10.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 09.10.20 | Novo Nordisk Neutral | UBS AG | |
| 09.10.20 | Novo Nordisk Verkaufen | DZ BANK | |
| 09.10.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.09.20 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.09.20 | Novo Nordisk Neutral | UBS AG | |
| 18.08.20 | Novo Nordisk Neutral | UBS AG | |
| 14.08.20 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 11.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.08.20 | Novo Nordisk Outperform | Bernstein Research | |
| 07.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
Werbung
Werbung